JAGUAR HEALTH, INC. Weighted Average Number of Shares Outstanding, Basic and Diluted
JAGUAR HEALTH, INC. (JAGX) reported Weighted Average Number of Shares Outstanding, Basic and Diluted of 134.44 million shares for the 3-month period ending 2021-06-30, per its 10-Q filed 2021-08-13.
Discontinued › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted · last filed 2021-08-13
- JAGUAR HEALTH, INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-06-30 was 134.44M shares, a 462.71% increase year-over-year.
- JAGUAR HEALTH, INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-03-31 was 125.42M shares, a 728.27% increase year-over-year.
- JAGUAR HEALTH, INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2020-12-31 was 75.17M shares, a 546.79% increase year-over-year.
- JAGUAR HEALTH, INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2020-09-30 was 40.22M shares, a 588.46% increase year-over-year.
- JAGUAR HEALTH, INC. weighted average number of shares outstanding, basic and diluted for fiscal 2020 was 38.64M shares, a 678.25% increase from fiscal 2019.
- JAGUAR HEALTH, INC. weighted average number of shares outstanding, basic and diluted for fiscal 2019 was 4.97M shares, a 2267.50% increase from fiscal 2018.
- JAGUAR HEALTH, INC. weighted average number of shares outstanding, basic and diluted for fiscal 2018 was 209.73K shares, a 92.76% decline from fiscal 2017.
- JAGUAR HEALTH, INC. weighted average number of shares outstanding, basic and diluted for fiscal 2017 was 2.90M shares, a 73.56% decline from fiscal 2016.
| Period end | Weighted Average Number of Shares Outstanding, Basic and Diluted 3 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 3 month as first filed | Weighted Average Number of Shares Outstanding, Basic and Diluted 6 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 6 month as first filed | Weighted Average Number of Shares Outstanding, Basic and Diluted 9 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 12 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2021-06-30 | 134.44M shares 10-Q · filed 2021-08-13 | 129.95M shares 10-Q · filed 2021-08-13 | 111.67M shares derived: average of 3 quarters · filed 2021-08-13 | 93.81M shares derived: average of 4 quarters · filed 2021-08-13 | |||
| 2021-03-31 | 125.42M shares 10-Q · filed 2021-05-17 | 100.29M shares derived: average of 2 quarters · filed 2021-05-17 | 80.27M shares derived: average of 3 quarters · filed 2021-05-17 | 66.17M shares derived: average of 4 quarters · filed 2021-08-13 | |||
| 2020-12-31 | 75.17M shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-31 | 57.69M shares derived: average of 2 quarters · filed 2021-03-31 | 46.43M shares derived: average of 3 quarters · filed 2021-08-13 | 38.64M shares 10-K · filed 2021-03-31 | |||
| 2020-09-30 | 40.22M shares 10-Q · filed 2020-11-16 | 32.05M shares derived: average of 2 quarters · filed 2021-08-13 | 26.47M shares 10-Q · filed 2020-11-16 | 22.72M shares derived: average of 4 quarters · filed 2021-08-13 | |||
| 2020-06-30 | 23.89M shares 10-Q · filed 2021-08-13 | 19.52M shares 10-Q · filed 2021-08-13 | 16.88M shares derived: average of 3 quarters · filed 2021-08-13 | 14.12M shares derived: average of 4 quarters · filed 2021-08-13 | |||
| 2020-03-31 | 15.14M shares 10-Q · filed 2021-05-17 | 13.38M shares derived: average of 2 quarters · filed 2021-05-17 | 10.87M shares derived: average of 3 quarters · filed 2021-05-17 | 8.43M shares derived: average of 4 quarters · filed 2021-05-17 | |||
| 2019-12-31 | 11.62M shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-31 | 8.73M shares derived: average of 2 quarters · filed 2021-03-31 | 6.19M shares derived: average of 3 quarters · filed 2021-03-31 | 4.97M shares 10-K · filed 2021-03-31 | |||
| 2019-09-30 | 5.84M shares 10-Q · filed 2020-11-16 | 3.47M shares derived: average of 2 quarters · filed 2020-11-16 | 2.75M shares 10-Q · filed 2020-11-16 | 1.96M shares derived: average of 4 quarters · filed 2020-11-16 | |||
| 2019-06-30 | 1.11M shares 10-Q · filed 2020-08-13 | 801.48K shares 10-Q · filed 2020-08-13 | 669.82K shares derived: average of 3 quarters · filed 2020-08-13 | 542.99K shares derived: average of 4 quarters · filed 2020-08-13 | |||
| 2019-03-31 | 493.20K shares 10-Q · filed 2020-05-15 | 34.52M shares 10-Q · filed 2019-05-21 | 451.54K shares derived: average of 2 quarters · filed 2020-05-15 | 355.20K shares derived: average of 3 quarters · filed 2020-05-15 | 307.02K shares derived: average of 4 quarters · filed 2020-05-15 | ||
| 2018-12-31 | 409.88K shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-04-03 | 286.19K shares derived: average of 2 quarters · filed 2020-04-03 | 244.96K shares derived: average of 3 quarters · filed 2020-04-03 | 209.73K shares 10-K · filed 2020-04-03 | 14.68M shares 10-K · filed 2019-04-10 | ||
| 2018-09-30 | 162.51K shares 10-Q · filed 2019-11-14 | 162.51K shares derived: average of 2 quarters · filed 2019-11-14 | 143.01K shares 10-Q · filed 2019-11-14 | ||||
| 2018-06-30 | 162.51K shares 10-Q · filed 2019-08-14 | 11.38M shares 10-Q · filed 2018-08-13 | 143.01K shares 10-Q · filed 2019-08-14 | 10.01M shares 10-Q · filed 2018-08-13 | |||
| 2018-03-31 | 8.63M shares 10-Q · filed 2019-05-21 | 129.47M shares 10-Q · filed 2018-05-15 | |||||
| 2017-12-31 | 2.90M shares 10-K · filed 2019-04-10 | 43.44M shares 10-K · filed 2018-04-09 | |||||
| 2017-06-30 | 979.62K shares 10-Q · filed 2018-08-13 | 14.69M shares 10-Q · filed 2017-08-09 | 961.82K shares 10-Q · filed 2018-08-13 | 14.43M shares 10-Q · filed 2017-08-09 | 9.35M shares derived: average of 3 quarters · filed 2018-08-13 | 9.83M shares derived: average of 4 quarters · filed 2018-08-13 | |
| 2017-03-31 | 14.16M shares 10-Q · filed 2018-05-15 | 13.53M shares derived: average of 2 quarters · filed 2018-05-15 | 12.78M shares derived: average of 3 quarters · filed 2018-05-15 | 12.16M shares derived: average of 4 quarters · filed 2018-05-15 | |||
| 2016-12-31 | 12.91M shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-04-09 | 12.09M shares derived: average of 2 quarters · filed 2018-04-09 | 11.50M shares derived: average of 3 quarters · filed 2018-04-09 | 10.95M shares 10-K · filed 2018-04-09 | |||
| 2016-09-30 | 11.26M shares 10-Q · filed 2016-11-14 | 10.79M shares derived: average of 2 quarters · filed 2017-08-09 | 10.30M shares 10-Q · filed 2016-11-14 | 9.76M shares derived: average of 4 quarters · filed 2017-08-09 | |||
| 2016-06-30 | 10.31M shares 10-Q · filed 2017-08-09 | 9.81M shares 10-Q · filed 2017-08-09 | 9.26M shares derived: average of 3 quarters · filed 2017-08-09 | 8.97M shares derived: average of 4 quarters · filed 2017-08-09 | |||
| 2016-03-31 | 9.31M shares 10-Q/A · filed 2017-06-23 | 8.73M shares derived: average of 2 quarters · filed 2017-06-23 | 8.53M shares derived: average of 3 quarters · filed 2017-06-23 | 7.75M shares derived: average of 4 quarters · filed 2017-06-23 | |||
| 2015-12-31 | 8.15M shares derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-15 | 8.13M shares derived: average of 2 quarters · filed 2017-02-15 | 7.23M shares derived: average of 3 quarters · filed 2017-02-15 | 6.15M shares 10-K · filed 2017-02-15 | |||
| 2015-09-30 | 8.12M shares 10-Q · filed 2016-11-14 | 6.77M shares derived: average of 2 quarters · filed 2016-11-14 | 5.49M shares 10-Q · filed 2016-11-14 | 4.82M shares derived: average of 4 quarters · filed 2016-11-14 | |||
| 2015-06-30 | 5.41M shares 10-Q · filed 2016-08-15 | 4.15M shares 10-Q · filed 2016-08-15 | 3.72M shares derived: average of 3 quarters · filed 2016-08-15 | 3.51M shares derived: average of 4 quarters · filed 2016-08-15 | |||
| 2015-03-31 | 2.87M shares 10-Q · filed 2016-05-10 | 2.87M shares derived: average of 2 quarters · filed 2016-05-10 | 2.87M shares derived: average of 3 quarters · filed 2016-05-10 | 2.87M shares derived: average of 4 quarters · filed 2016-05-10 | |||
| 2014-12-31 | 2.87M shares derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-29 | 2.87M shares derived: average of 2 quarters · filed 2016-03-29 | 2.87M shares derived: average of 3 quarters · filed 2016-03-29 | 2.85M shares 10-K · filed 2016-03-29 | |||
| 2014-09-30 | 2.87M shares 10-Q · filed 2015-11-13 | 2.87M shares derived: average of 2 quarters · filed 2015-11-13 | 2.85M shares 10-Q · filed 2015-11-13 | ||||
| 2014-06-30 | 2.87M shares 10-Q · filed 2015-08-13 | 2.83M shares 10-Q · filed 2015-08-13 | |||||
| 2014-03-31 | 2.79M shares 10-Q · filed 2015-06-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| OPKO HEALTH, INC. (OPK) | United States | $1.220B | -15.59 |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| HARROW, INC. (HROW) | United States | $1.240B | -42.77 |
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |